Homology Medicines Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 4/6

Homology Medicines has a total shareholder equity of $73.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $84.6M and $11.6M respectively.

Wichtige Informationen

0%

Verhältnis von Schulden zu Eigenkapital

US$0

Verschuldung

Zinsdeckungsgradn/a
BargeldUS$82.65m
EigenkapitalUS$72.99m
GesamtverbindlichkeitenUS$11.57m
GesamtvermögenUS$84.56m

Jüngste Berichte zur Finanzlage

Recent updates

Homology Medicines (NASDAQ:FIXX) Will Have To Spend Its Cash Wisely

Nov 16
Homology Medicines (NASDAQ:FIXX) Will Have To Spend Its Cash Wisely

Homology Medicines appoints new CEO, chairperson

Sep 06

Homology announces peer-reviewed preclinical data publication on its AAVHSC16 capsid

Jul 05

Here's Why We're Watching Homology Medicines' (NASDAQ:FIXX) Cash Burn Situation

Jan 28
Here's Why We're Watching Homology Medicines' (NASDAQ:FIXX) Cash Burn Situation

Homology Medicines: In Vivo Gene Therapy Platform With Delayed Lead Trial Coming Back Online

Oct 22

We Think Homology Medicines (NASDAQ:FIXX) Can Afford To Drive Business Growth

Sep 18
We Think Homology Medicines (NASDAQ:FIXX) Can Afford To Drive Business Growth

Growth Investors: Industry Analysts Just Upgraded Their Homology Medicines, Inc. (NASDAQ:FIXX) Revenue Forecasts By 20%

Aug 14
Growth Investors: Industry Analysts Just Upgraded Their Homology Medicines, Inc. (NASDAQ:FIXX) Revenue Forecasts By 20%

Industry Analysts Just Made A Sizeable Upgrade To Their Homology Medicines, Inc. (NASDAQ:FIXX) Revenue Forecasts

May 22
Industry Analysts Just Made A Sizeable Upgrade To Their Homology Medicines, Inc. (NASDAQ:FIXX) Revenue Forecasts

Homology Medicines (FIXX) Investor Presentation - Slideshow

May 05

Homology Medicines (NASDAQ:FIXX) Is In A Good Position To Deliver On Growth Plans

Apr 17
Homology Medicines (NASDAQ:FIXX) Is In A Good Position To Deliver On Growth Plans

Are Institutions Heavily Invested In Homology Medicines, Inc.'s (NASDAQ:FIXX) Shares?

Mar 13
Are Institutions Heavily Invested In Homology Medicines, Inc.'s (NASDAQ:FIXX) Shares?

Homology Medicines' (NASDAQ:FIXX) Stock Price Has Reduced 25% In The Past Year

Feb 03
Homology Medicines' (NASDAQ:FIXX) Stock Price Has Reduced 25% In The Past Year

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: FIXX's short term assets ($83.9M) exceed its short term liabilities ($11.6M).

Langfristige Verbindlichkeiten: FIXX has no long term liabilities.


Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: FIXX is debt free.

Schulden abbauen: FIXX has not had any debt for past 5 years.


Bilanz


Liquiditätsreserve-Analyse

Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.

Stabile Start- und Landebahn für Bargeld: FIXX has less than a year of cash runway based on its current free cash flow.

Vorhersage Cash Runway: FIXX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 16.2% each year


Entdecken Sie finanziell stabile Unternehmen